Kalb Michael Wayne 4
4 · CinCor Pharma, Inc. · Filed Nov 8, 2022
Insider Transaction Report
Form 4
Kalb Michael Wayne
EVP & Chief Financial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2022-11-04+77,615→ 77,615 totalExercise: $30.07Exp: 2032-11-03→ Common Stock (77,615 underlying) - Award
Common Stock
2022-11-04+25,437→ 25,437 total
Footnotes (2)
- [F1]Represents a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-half (1/2) of the RSUs shall vest on November 4, 2024 and the remaining RSUs shall vest in two (2) equal annual installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.
- [F2]One-fourth (1/4th) of the shares subject to the option vest on November 4, 2023, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.